Akpash Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.40 M
as on 08-01-2025
- Paid Up Capital ₹ 2.07 M
as on 08-01-2025
- Company Age 20 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.95 Cr
as on 08-01-2025
- Satisfied Charges ₹ 8.00 M
as on 08-01-2025
- Revenue -19.12%
(FY 2021)
- Profit -12.94%
(FY 2021)
- Ebitda -24.45%
(FY 2021)
- Net Worth -604.17%
(FY 2021)
- Total Assets 14.02%
(FY 2021)
About Akpash Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.40 M and a paid-up capital of Rs 2.07 M.
The company currently has active open charges totaling ₹1.95 Cr. The company has closed loans amounting to ₹8.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ravindra Mandloi and Virendra Mandloi serve as directors at the Company.
- CIN/LLPIN
U24233MP2004PTC016579
- Company No.
016579
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Apr 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Akpash Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravindra Mandloi  | Director | 12-Jul-2018 | Current |
| Virendra Mandloi | Director | 12-Jul-2018 | Current |
Financial Performance of Akpash Pharmaceuticals.
Akpash Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 19.12% decrease. The company also saw a substantial fall in profitability, with a 12.94% decrease in profit. The company's net worth observed a substantial decline by a decrease of 604.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Akpash Pharmaceuticals?
In 2021, Akpash Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gurjar Phytochem Private LimitedActive 13 years 18 daysRavindra Mandloi and Virendra Mandloi are mutual person
Gurjar Chemicals Private LimitedActive 18 years 10 monthsRavindra Mandloi and Virendra Mandloi are mutual person
Dyna Technocem Pvt LtdActive 28 years 11 monthsRavindra Mandloi and Virendra Mandloi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Jul 2017 | ₹1.15 Cr | Open |
Allahabad Bank Creation Date: 20 Nov 2009 | ₹8.00 M | Open |
State Bank Of Indore Creation Date: 18 Nov 2005 | ₹1.50 M | Satisfied |
How Many Employees Work at Akpash Pharmaceuticals?
Akpash Pharmaceuticals has a workforce of 6 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Akpash Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akpash Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
